#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Recommended tools for medication review and prescription optimization in geriatric patients


Authors: Topinková Eva 1;  Fialová Daniela 1,2
Authors‘ workplace: Geriatrická klinika 1. LF UK a VFN Praha 1;  Katedra sociální a klinické farmacie FaF UK Hradec Králové 2
Published in: Geriatrie a Gerontologie 2023, 12, č. 3: 114-126
Category:

Overview

In the last two decades the number of drugs prescribed to the older patients is increasing steadily. Polypharmacy – despite being beneficial in the treatment of multimorbid patients –also confers a risk of medication-related adverse reactions such as drug-drug interactions, adverse drug events, inappropriate drug prescription, higher level of frailty and increased mortality in some studies. Evaluating of prescribed and used medication by a geriatrician is an integral part of geriatric clinical approach. For medication review, identification of potentially inappropriate and risky medications use, but also detection of potentially beneficial but not (yet) prescribed medications, evaluation of their effectiveness and safety in the context of chronic co-morbidities, geriatric syndromes and frailty.

To evaluate quality of drug prescribing in older age standardized instruments could be used. Among many existing tools STOPP/START explicit criteria of potentially inappropriate and potentially beneficial medications in patients 65 years and older are currently recommended. For specific situations e.g. for patients with frailty syndrome, disability and limited life expectancy STOPP-Frail criteria seems to be the most suitable tool, for patients with the high risk of falls or falls in the recent history STOPP-Fall criteria enables to identify fall-risk medications, and for those with cognitive impairment drugs with stronger anticholinergic properties should be avoided. 

Medication review with the use of the above-mentioned explicit tools enables systematic deprescribing of drugs without valid indication, of drugs inappropriate in old age in general and in an individual patient in particular, to avoid using duplicate medications, as well as drugs which are not in line with patient goals and preferences. The geriatric medication review address also problems of „underprescribing“, when beneficial drug is not prescribed. Medication review is a procedure which results in rational and optimal prescription, improves its safety, prevents adverse drug events, and their related costs. This article reviews current standardized and validated tools and supports their use by clinicians during (regular) comprehensive assessment of medication in ambulatory and hospital clinical care. 

Keywords:

Falls – polypharmacy – medication review – tools for geriatric prescribing optimization – explicit crtieria- geriatric frailty – anticholinergic medications


Sources
  1. Kaufman DW, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287(3): 337–344.
  2. Fialová D, Halačová M, Brkič J, et al. Klinická farmacie v geriatrii a 20 let klinických a výzkumných zkušeností s hodnocením racionality geriatrické preskripce v České republice a v evropských zemích. Klin Farmakol Farm 2020; 34(3): 122–129.
  3. Onder G, Bonassi S, Abbatecola AM, et al. High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci 2014; 69(4): 430–437.
  4. Thomsen LA, et al. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007; 41(9): 1411–1426.
  5. Topinkova E. Aging, disability and frailty. Ann Nutr Metab 2008; 52(Suppl. 1): 6–11.
  6. Mangin D, Bahat G, Golomb BA, et al. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action. Drugs Aging 2018; 35: 575–587. 
  7.  Aggarwal P, Woolford SJ, Patel HP. Multi-morbidity and polypharmacy in older people: Challenges and opportunities for clinical practice. Geriatrics 2020; 5(4): 85. 
  8. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014; 13(1): 57–65.
  9. Kameníková L, Farghal H. Problematika polypragmazie, polymorbidity, adherence a compliance. Zdravotnictví a medicína 2014; 18(Sestra): 25. 
  10. Global Patient Safety Challenge: Medication Without Harm. WHO Global Patient Safety Challenge, WHO 2017.
  11. Medication Safety in Polypharmacy. Technical report. WHO 2019.
  12. Zazzara MB, Palmer K, Vetrano DL, et al. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med 2021; 12(3): 463–473. 
  13. Beuscart JB, Pelayo S, Robert L, et al. Medication review and reconciliation in older adults. Eur Geriatr Med 2021; 12(3): 499–507. 
  14. Topinková E, Baeyens JP, Michel JP, et al. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging 2012; 29: 477–494. 
  15. Topinková E. Redukce nevhodné a neúčelné farmakoterapie – deprescribing. Geri a Gero 2020; 9(1): 9–14.
  16. Reeve E, Gnjidic D, Long J, et al. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 2015; 80(6): 1254–1268. 
  17. Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 2003; 33: 323–328. 
  18. Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 2015; 175(5): 827–834. 
  19. Machado-Alba JE, Gaviria-Mendoza A, Machado-Duque ME, et al. Deprescribing: a new goal focused on the patient. Expert Opin Drug Saf 2017; 16(2): 111–112. 
  20. McKean M, Pillans P, Scott IA. A medication review and deprescribing method for hospitalised older patients receiving multiple medications. Intern Med J 2016; 46: 35–42.
  21. Farrell B, Mangin D. Deprescribing is an essential part of good prescribing. Am Fam Physician 2019; 99: 7–9.
  22. Reeve E, et al. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc 2013; 61(9): 1508–1514.
  23. Tannenbaum C, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med 2014; 174(6): 890–898.
  24. Fialová D. Specifické rysy racionální geriatrické farmakoterapie: role klinických farmaceutů v individualizované léčbě ve stáří. Vnitr Lek 2018; 64(11): 1028–1034. 
  25. Pazan F, Kather J, Wehling M. A systematic review and novel classification of listing tools to improve medication in older people. Eur J Clin Pharmacol 2019; 75: 619–625. 
  26. American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2023, May 4. 
  27. Fialová D, Topinková E, Ballóková A, et al. Expertní konsenzus ČR 2012 v oblasti léčiv a lékových postupů potenciálně nevhodných ve stáří. Klin Farmakol Farm 2013; 27(1): 18–28.
  28. Pazan F, Weiss C, Wehling M. The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults. Drugs Aging 2022; 39(3): 245-247. Erratum in: Drugs Aging 2022; 39(6): 485. 
  29. Pazan F, Weiss C, Wehling M. FORTA Expert Panel Members. The EURO-FORTA (Fit fOR The Aged) List Version 2: Consensus Validation of a Clinical Tool for Improved Pharmacotherapy in Older Adults. Drugs Aging 2023; 40(5): 417–426. 
  30. O’Mahony D, O’Sullivan D, Byrne S. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 44(2): 213–118. 
  31. Seppala LJ, Petrovic M, Ryg J, et al. STOPP-Fall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age Ageing 2021; 50(4): 1189–1199. 
  32. Topinková E. Doporučení pro screening a stratifikaci rizika pádu u seniorů z pohledu nových „celosvětových guidelines pro prevenci a management pádů u starších osob“. Geri Gero 2023; 12 (1): 12–17.
  33. Seppala LJ, Kamkar N, van Poelgeest EP, et al. Task Force on Global Guidelines for Falls in Older Adults. Medication reviews and deprescribing as a single intervention in falls prevention: a systematic review and meta-analysis. Age Ageing 2022; 51(9): afac191. 
  34. Curtin D, Gallagher P, O’Mahony D. Deprescribing in older people approaching end-of-life: development and validation of STOPP-Frail version 2. Age Ageing 2021; 50(2): 465–471. 
Labels
Geriatrics General practitioner for adults Orthopaedic prosthetics

Article was published in

Geriatrics and Gerontology

Issue 3

2023 Issue 3

Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#